NIH looks for pediatric biomarker proposals

It has been estimated that 70% of the medicines given to children have only been tested in adults. The same is true when it comes to biomarkers. So, the NIH has opened up a new funding program aimed at taking biomarkers that may be effective in adults and developing them further for children. The NIH is accepting proposals for biomarkers developed in adults for use in pediatric diagnosis, prognosis and estimation of disease progression, toxicity and response to therapies. Story

Suggested Articles

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,